Generics

In a high competitive and growth market, MOEHS has been able to stand as one of the main participants worldwide.

THE KEY FACTORS THAT CONFIRMS THIS TREND ARE:

  • Consolidation of a wide range of products with different therapeutic areas: from mucolytics to ß-blocants.
  • Continuous enlargement of the API list.
  • Optimum ratio between cost and services offered.
  • Understanding of needs communicated by customers and transferring them to our product range.
  • Documental and Regulatory support.